The COVID-19 crisis requires a rapid, coordinated research effort to reduce the spread of SARS-CoV-2, the virus that causes COVID-19, and minimise the loss of life. At the Crick, our excellence in discovery research, diverse science base, focus on human biology and links with clinical hospitals and global research collaborators, such as the World Health Organization, make us well placed to drive progress in the fight against COVID-19 and SARS-CoV-2.
To support the national and global effort, we have devised a research strategy that addresses the immediate practical challenges of controlling the virus, whilst seeking to deliver more definitive therapeutic solutions in the longer term. Our comprehensive COVID-19 research programme brings together a team of approximately 110 world-leading scientists across 12 laboratories, who will focus their expertise and energy on finding solutions to some of the most pressing challenges posed by COVID-19 and SARS-CoV-2.
Read the full report here: Lay summary of the Crick COVID-19-related research strategy – July 2020.